Target- |
MechanismImmunostimulants |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date13 Jan 2013 |
100 Clinical Results associated with Glaxosmithkline Vaccines Srl
0 Patents (Medical) associated with Glaxosmithkline Vaccines Srl
100 Deals associated with Glaxosmithkline Vaccines Srl
100 Translational Medicine associated with Glaxosmithkline Vaccines Srl